| ISSN |
2220-3206 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Integrative & Complementary Medicine |
| Manuscript Type |
Observational Study |
| Article Title |
Shugan Jieyu capsule effects on peripheral blood micro-124, micro-132, and brain-derived neurotrophic factor in patients with mild to moderate depression
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Xian Zhang, Yang Liu, Hua-Fei Tang, Feng Jiang, Chun-Liang Chen, Ting-Ting Wang, Hui-Zhong Gu, Qiang Zhao and Rui Ma |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| the 305 Hospital Independent Scientific Research Fund, 2024 |
24ZZJJLW-022 |
|
| Corresponding Author |
Rui Ma, MD, Department of Pharmacy, The 305 Hospital of People’s Liberation Army, No. A13 Wenjin Street, Xicheng District, Beijing 100017, China. maruipla@126.com |
| Key Words |
Shugan Jieyu capsule; Coronary heart disease; Depression; Escitalopram oxalate tablet; Micro-124; Micro-132; Brain-derived neurotrophic factor |
| Core Tip |
The study examines the effects of Shugan Jieyu capsules on patients with mild to moderate depression following percutaneous coronary intervention for coronary heart disease. The results indicate significant improvements in depressive symptoms, biochemical markers such as miR-124, miR-132, and brain-derived neurotrophic factor, as well as immune function. Shugan Jieyu capsules outperformed escitalopram oxalate tablets in reducing depression severity and adverse reactions, suggesting their potential as a safer and more effective treatment alternative for post-percutaneous coronary intervention depression. |
| Publish Date |
2024-09-11 07:02 |
| Citation |
<p>Zhang X, Liu Y, Tang HF, Jiang F, Chen CL, Wang TT, Gu HZ, Zhao Q, Ma R. Shugan Jieyu capsule effects on peripheral blood micro-124, micro-132, and brain-derived neurotrophic factor in patients with mild to moderate depression. <i>World J Psychiatry</i> 2024; 14(9): 1354-1363</p> |
| URL |
https://www.wjgnet.com/2220-3206/full/v14/i9/1354.htm |
| DOI |
https://dx.doi.org/10.5498/wjp.v14.i9.1354 |
